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Gastric outlet obstruction (GOO) in children is most commonly caused by idiopathic hypertrophic pyloric stenosis. Prior to
proton pump inhibitors and H2 blockers, peptic ulcer disease (PUD) secondary to H. pylori was a cause of GOO. Both patients
presented with a history of weight loss, vomiting, and abdominal pain. Their diagnosis of PUD and GOO was made by EGD
and UGI. H. pylori testing was negative for both on multiple occasions but still received H. pylori eradication therapy. Patient 1
after failing pharmaceutical management underwent surgery for deﬁnitive treatment. Patient 2 underwent six therapeutic pyloric
dilations before undergoing surgery as deﬁnitive treatment. These cases suggest that GOO secondary to PUD occurs in the absence
of H. pylori infection and surgical management can provide deﬁnitive therapy.
1.Introduction
Gastric outlet obstruction (GOO) is a well-identiﬁed entity
leading to the clinical symptoms of abdominal pain and
vomiting. Prior to the introduction of proton pump
inhibitors(PPIs)andH2blockers(H2Bs)pepticulcerdisease
(PUD) secondary to H. pylori infection was recognized as a
common cause of GOO. In infants, GOO is usually caused
by idiopathic hypertrophic pyloric stenosis (IHPS) [1],
although other anatomic abnormalities can cause obstruc-
tion; in children, GOO is less common [2].
2.Case1
Patient 1 is an 11-year-old male who presented with a 3-year
history of postprandial vomiting and abdominal pain, 1.5kg
weightloss,andplateauinheight.Weightatpresentationwas
28.3kg (7th percentile), height 144.5cm (54th percentile),
and BMI 13.5 (<5 percentile). On examination only asthenia
was noted. The complete blood count, electrolytes, erythro-
cyte sedimentation rate, stool elastase, and 72-hour fecal
fat were normal. Stool examinations for H. pylori antigen,
hemoccult, bacteria, and viruses were negative.
Anesophagogastroduodenoscopy(EGD)withastandard
endoscope showed retained food and liquid in the stomach
despite 18 hours of fasting. Visual examination showed
thickened mucosal folds along the lesser curvature and
stenosis of the pylorus with no visible ulcers. The patient was
started on lansoprazole 30mg daily.
Rapidureasetest(Campylobacter-likeorganism,CLOtest,
Kimberly-Clark, Roswell, GA) of the gastric antrum and
fundus was negative, upper gastrointestinal series (UGI)
showed a narrowed pyloric channel, and computed tomog-
raphy (CT) of the abdomen/pelvis and pyloric ultrasound
were normal. The patient became asymptomatic, and the
lansoprazole was stopped after 6 months of therapy.
Seven months later, the patients symptoms recurred, and
lansoprazole, 30mg/day, and nutritional supplementation
were started. One month later, the patient lost 2.5kg.
Repeat EGD showed stenosis of the pyloric sphincter; lumen
diameterestimatedat3mm(Figure 1),gastrinwas27pg/mL
(normal 0–100), and a repeat CLO was negative. Pathology
from the pyloric channel showed necrotic tissue with
neutrophilic and ﬁbrinous exudates; adjacent gastric mucosa
showed active inﬂammation. The patient was admitted for2 Case Reports in Gastrointestinal Medicine
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high-dose proton-pump inhibitor treatment (pantoprazole
40mg IV bid) and parenteral nutrition. UGI showed a
narrow pyloric channel with ulceration and cicatrization
(Figure 2). Barium remained in the stomach after 18 hours.
An EGD eight months after initial presentation showed
a small pylorus that could not be traversed with a 6mm
endoscope (Pentax EG1870K, Pentax Medical, Montvale,
NJ). Histology of the duodenum showed benign mucosa
containing a lymphoid follicle and no active inﬂammation.
The antrum showed mild active gastritis. Serum studies
and colonoscopy were not suggestive of Crohn’s disease.
The patient was referred for surgical intervention. In the
operating room a dilated stomach and a 1–1.5cm thickened
area of the pyloric channel were observed. A Jaboulay
pyloroplasty was performed. The resected section showed
an ulcer, with normal smooth muscle and hypertrophic
nerves. The surface epithelium was replaced by granulation
tissue. The lamina propria showed mild active chronic
inﬂammation. No etiologic source for the hypertrophy was
identiﬁed.
Three months following surgery, 10 months after initial
presentation, the patient was asymptomatic; his weight was
41.2kg(48thpercentile)andheight148cm(38thpercentile).
Figure 3
3.Case2
Patient 2 is a 15-year-old female who presented with a
2-month history of vomiting and weight loss. Laboratory
evaluation prior to referral included normal H. pylori IgG
and abdominal ultrasound. A large pyloric channel ulcer was
seen on UGI. Weight was 53.8kg (50% tile), height 160cm
(35% tile), and physical exam unremarkable.
She was treated for H. pylori. The EGD demonstrated a
narrowed pyloric channel (Figure 3) and mucosal abnormal-
ities. The pyloric channel was dilated with CRE Wire-guided
6-7-8 180cm pyloric balloon dilator (Boston Scientiﬁc,
Natick,MA).Biopsiesshowednormalhistologyoftheesoph-
agus and antrum and no tissue from the duodenal bulb.
Repeat ultrasound revealed GOO caused by thickening of
the pylorus channel length 3.2cm, thickness 1.2cm. Biopsies
were negative for H. pylori, and serum gastrin and thyroid
levels were normal. Over the next 6 weeks the patient had a
total of 7 diltations, each resulting in transient improvement
in symptoms. Surgical referral was made following the sec-
ond dilatation, and following a failed seventh dilatation she
underwent a Billroth I gastrectomy with preservation of the
vagal nerve. Pathology of the stenosed area showed muscular
hypertrophy with no identiﬁable etiology. Following surgery
all symptoms of GOO resolved, and follow-up EGD 18
months after surgery showed no ulcer and no scaring.
4. Discussion
Excluding infancy GOO is a rare condition. The rate of
GOO in the pediatric/adolescent population is unknown.
Etiologies of GOO after the neonatal period include peptic
ulcer disease; gastric tumors, including adenocarcinoma,
lymphoma [3], and gastrointestinal stromal tumors; infec-
tions, such as tuberculosis; eosinophilic gastroenteritis [4]
and inﬁltrative diseases, such as amyloidosis [5]. Most of the
informationonthesuccessfultreatmentofGOOcomesfrom
the adult literature. The approach to management in adultsCase Reports in Gastrointestinal Medicine 3
has been applied to children without evidence to show its
eﬀectiveness in children.
H. pylori positive GOO is successfully treated with PPI
and antibiotic therapy [6–8]. H. pylori negative peptic ulcer
disease (PUD) is usually managed with dilatation and PPI.
Lau et al. [9] in a case series of 41 patients with benign
GOO reported that 6 of 10 patients who had a negative
CLO test responded to NG suction and IV PPI therapy,
and three patients developed recurrent obstruction and
required surgery. In a series of 23 patients with PUD-related
GOO Cherian [10] identiﬁed 3 patients with idiopathic
obstruction and all three improved on acid suppression
therapy alone.
In addition to PPI therapy benign GOO can be treated
with serial dilations [11, 12]h o w e v e r[ 9, 13–15] patients
requiring repeat dilatations eventually require surgery as
deﬁnitive therapy. The role of H. pylori therapy in PUD-
related GOO is less clear although eradication is warranted
as a primary intervention [16]. Lam et al. [17] reported that
in H. pylori-negative patients undergoing dilatation, the rate
of recurrent obstruction was 4/11 and was not signiﬁcantly
diﬀerent from the rate of recurrent obstruction in the H.
pylori-positive group. Gibson et al. [13] concluded that
patientswithH.pylori-negativePUDleadingtoGOOshould
have early surgery because of high recurrence of obstruction.
In children, cases of GOO outside of infancy have been
reported that are non-PUD-related [18]. Edwards et al. [19]
identiﬁed 29 cases of gastric outlet obstruction during a 23-
year period. Nineteen of these patients had duodenal ulcers,
and all underwent a surgical procedure. The presence of H.
pylori was not routinely assessed, and these patients were
not treated with PPI and/or dilitations. Yen and Kong [20]
identiﬁed 11 children without IHPS. Six patients had PUD-
related obstruction, and 3 were H. pylori negative. In the
H. pylori negative cohort only one patient required surgical
intervention; the other two patients had resolution with PPI
therapy only.
We conclude that GOO secondary to ulceration can
occur in the absence of H. pylori infection. Our patients
demonstrate that medical management was palliative but
deﬁnitive management was surgical.
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